- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有64家主力机构披露2026-06-30报告期持股数据，持仓量总计7.86亿股，占流通A股58.59%
- 波段诊断：
-
技术面诊股
诊断结果：6.6技术面打败了78%的股票
技术面评分前10的股票
近期的平均成本为8.31元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为8.31元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.31","date":1793867853,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.11.06","stock":"-0.84","trade":"-1.77","ind":"-1.10"},{"date":"2026.11.05","stock":"-0.24","trade":"2.29","ind":"0.10"},{"date":"2026.11.04","stock":"0.60","trade":"2.96","ind":"2.16"},{"date":"2026.11.03","stock":"1.09","trade":"-0.88","ind":"-0.82"},{"date":"2026.11.02","stock":"0.98","trade":"1.70","ind":"1.08"},{"date":"2026.10.30","stock":"1.24","trade":"-1.05","ind":"-1.44"},{"date":"2026.10.29","stock":"-0.25","trade":"-1.88","ind":"-0.82"},{"date":"2026.10.28","stock":"-0.49","trade":"1.46","ind":"0.91"},{"date":"2026.10.27","stock":"-1.69","trade":"-3.85","ind":"-1.33"},{"date":"2026.10.26","stock":"1.85","trade":"0.14","ind":"0.19"},{"date":"2026.10.23","stock":"0.12","trade":"1.64","ind":"0.89"},{"date":"2026.10.22","stock":"-1.46","trade":"-3.34","ind":"-1.48"},{"date":"2026.10.21","stock":"-0.24","trade":"0.13","ind":"-0.60"},{"date":"2026.10.20","stock":"-0.72","trade":"1.00","ind":"0.12"},{"date":"2026.10.19","stock":"-0.36","trade":"-1.42","ind":"0.39"},{"date":"2026.10.16","stock":"-0.83","trade":"-0.03","ind":"0.24"},{"date":"2026.10.15","stock":"-1.75","trade":"-1.39","ind":"-1.59"},{"date":"2026.10.14","stock":"1.06","trade":"-1.41","ind":"-0.88"},{"date":"2026.10.13","stock":"-1.28","trade":"-0.78","ind":"0.10"},{"date":"2026.10.12","stock":"0.71","trade":"-2.33","ind":"-0.43"},{"date":"2026.10.09","stock":"1.07","trade":"1.57","ind":"0.05"}]
国药现代,上证指数,化学制药指数
压力支撑
该股压力位为8.29元，支撑位为8.23元。
[{"text":"\u538b\u529b\u4f4d","value":"8.29","date":1793894400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.23","date":1793894400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.9资金面打败了74%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：11月06日 17:36
| 机构今日流向(万元) | -1250.50 | 机构5日流向(万元) | 3064.89 |
| 机构10日流向(万元) | 326.17 | 机构20日流向(万元) | -7743.00 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少2892.93万股，其中基金净减仓15家，主力净减仓42家，请投资者中长期谨慎为宜。
截止2026-06-30，共64家主力机构（基金57家，一般法人7家），持仓量总计78578.75万股，占流通A股58.59%
其中，基金持仓与2025-12-31相比：
增仓：10家 ，增持 9.91万股
减仓：25家 ，减持 1316.27万股
新出现在主力名单中：17家 ，持有42.72万股
从主力名单中消失：59家 ，原持有1629.29万股
其中，基金持仓与2025-12-31相比：
增仓：10家 ，增持 9.91万股
减仓：25家 ，减持 1316.27万股
新出现在主力名单中：17家 ，持有42.72万股
从主力名单中消失：59家 ，原持有1629.29万股
消息面诊股
诊断结果：4.8消息面打败了3%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 国药现代：11月5日获融资买入496.93万元
2026-11-06 - 国药现代：关于全资子公司获得药品注册证书的公告
2026-11-05 - 国药现代：全资子公司盐酸尼卡地平注射液获药品注册证
2026-11-05 - 国药现代：控股子公司撤回环磷酰胺注射液注册申请
2026-11-05 - 国药现代：11月4日获融资买入469.13万元
2026-11-05 - 22款独家皮肤科中成药火爆！7大品种涨逾20%，汉
2026-11-04 - 国药现代：11月3日获融资买入516.03万元
2026-11-04 - 国药现代：公司将按照正常管理节奏统筹日常各项经营管
2026-11-03 - 国药现代：11月2日获融资买入414.50万元
2026-11-03 - 国药现代前三季度营业收入55.85亿元，同比下降1
2026-11-03
消息列表
| 一般消息 | 高管变动 | 工作调整 | 2026-10-30 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-10-23 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-10-15 |
| 利好 | 分红转增 | 10派0.5元(含税) | 2026-08-27 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-08-20 |
| 一般消息 | 重大事项 | 关联交易 | 2026-08-20 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-04 |
| 一般消息 | 高管变动 | 达到退休年龄 | 2026-07-31 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-07-31 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-07-11 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-09 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-04-11 |
| 利好 | 分红转增 | 10派2元(含税) | 2026-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-28 |
| 一般消息 | 高管变动 | 任期届满不再担任 | 2025-12-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 3条 | 3条 | 0条 |
行业面诊股
诊断结果：6.4行业面打败了84%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2026.11.06","price":"-1.10","value":"-1.77"},{"date":"2026.11.05","price":"0.10","value":"2.29"},{"date":"2026.11.04","price":"2.16","value":"2.96"},{"date":"2026.11.03","price":"-0.82","value":"-0.88"},{"date":"2026.11.02","price":"1.08","value":"1.70"},{"date":"2026.10.30","price":"-1.44","value":"-1.05"},{"date":"2026.10.29","price":"-0.82","value":"-1.88"},{"date":"2026.10.28","price":"0.91","value":"1.46"},{"date":"2026.10.27","price":"-1.33","value":"-3.85"},{"date":"2026.10.26","price":"0.19","value":"0.14"},{"date":"2026.10.23","price":"0.89","value":"1.64"},{"date":"2026.10.22","price":"-1.48","value":"-3.34"},{"date":"2026.10.21","price":"-0.60","value":"0.13"},{"date":"2026.10.20","price":"0.12","value":"1.00"},{"date":"2026.10.19","price":"0.39","value":"-1.42"},{"date":"2026.10.16","price":"0.24","value":"-0.03"},{"date":"2026.10.15","price":"-1.59","value":"-1.39"},{"date":"2026.10.14","price":"-0.88","value":"-1.41"},{"date":"2026.10.13","price":"0.10","value":"-0.78"},{"date":"2026.10.12","price":"-0.43","value":"-2.33"},{"date":"2026.10.09","price":"0.05","value":"1.57"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 莱美药业 | 78.43% | -1.71% | 5.8分 |
| 2 | 昂利康 | 15.34% | 25.69% | 6.5分 |
| 3 | 百利天恒 | 15.22% | 8.26% | 5.5分 |
| 4 | 科伦药业 | 13.87% | 12.28% | 5.9分 |
| 5 | 海正药业 | 12.23% | 3.47% | 5.5分 |
| 6 | 迪哲医药 | 11.96% | 20.35% | 6.6分 |
| 8 | 百济神州 | 11.70% | 11.78% | 5.2分 |
| 10 | 健友股份 | 8.56% | 9.90% | 6.7分 |
| 12 | 丽珠集团 | 6.34% | 9.92% | 7.1分 |
| 14 | 恩华药业 | 5.20% | 5.83% | 6.2分 |
| 16 | 泰恩康 | 4.55% | 5.82% | 6.3分 |
| 18 | 京新药业 | 3.71% | 9.42% | 6.3分 |
| 20 | 华邦健康 | 2.84% | 7.55% | 6.5分 |
| 22 | 翰宇药业 | 1.81% | 10.43% | 5.3分 |
| 24 | 华东医药 | 1.58% | 4.13% | 6.5分 |
| 26 | 华海药业 | 0.92% | 8.30% | 6.4分 |
| 28 | 新和成 | 0.68% | 4.53% | 6.2分 |
| 30 | 亿帆医药 | -0.62% | 4.01% | 6.0分 |
| 32 | - | -0.98% | 3.97% | 分 |
| 34 | 复星医药 | -1.30% | 4.06% | 6.3分 |
| 36 | 贝达药业 | -2.25% | 18.05% | 6.4分 |
| 38 | 通化金马 | -2.40% | 5.95% | 5.5分 |
| 40 | 首药控股 | -2.93% | 6.39% | 4.9分 |
| 42 | ST南新 | -3.28% | 7.64% | 4.7分 |
| 44 | 海思科 | -3.54% | 7.37% | 6.4分 |
| 46 | 福元医药 | -4.45% | 3.09% | 6.5分 |
| 48 | 海普瑞 | -4.55% | 2.39% | 5.9分 |
| 50 | 诚意药业 | -4.81% | 0.60% | 6.0分 |
| 52 | ST诺泰 | -5.07% | 3.07% | 4.7分 |
| 54 | 东诚药业 | -5.11% | 3.21% | 5.5分 |
| 56 | 天新药业 | -5.28% | -0.49% | 5.1分 |
| 58 | 小方制药 | -5.90% | 3.28% | 5.2分 |
| 60 | 九典制药 | -6.32% | 4.16% | 5.4分 |
| 62 | 天宇股份 | -6.90% | 4.56% | 6.1分 |
| 64 | 广生堂 | -7.05% | 4.54% | 4.8分 |
| 66 | - | -7.18% | 0.44% | 分 |
| 68 | 同和药业 | -8.10% | 1.23% | 5.3分 |
| 70 | 德展健康 | -8.59% | 6.05% | 4.6分 |
| 72 | 海翔药业 | -8.86% | 3.97% | 5.3分 |
| 74 | 国邦医药 | -9.24% | 4.45% | 6.1分 |
| 76 | 苑东生物 | -9.40% | 1.95% | 4.6分 |
| 78 | 东北制药 | -9.78% | 2.07% | 5.2分 |
| 80 | 卫信康 | -10.24% | -1.55% | 4.7分 |
| 82 | 华纳药厂 | -10.39% | 1.73% | 4.6分 |
| 84 | 纳微科技 | -10.75% | -1.17% | 5.4分 |
| 86 | 石药景峰 | -10.80% | 7.83% | 5.3分 |
| 88 | 科源制药 | -11.05% | 8.63% | 6.1分 |
| 90 | 本立科技 | -11.52% | 2.63% | 5.3分 |
| 92 | 亚太药业 | -11.71% | 6.48% | 4.8分 |
| 94 | 富士莱 | -11.98% | 6.30% | 4.6分 |
| 96 | 立方制药 | -12.14% | 2.70% | 5.4分 |
| 98 | 奥翔药业 | -12.45% | -1.38% | 4.2分 |
| 100 | - | -12.53% | -0.75% | 分 |
| 102 | 山河药辅 | -12.77% | 4.32% | 5.2分 |
| 104 | 泽璟制药 | -12.90% | 11.29% | 5.5分 |
| 106 | 微芯生物 | -13.12% | 6.34% | 5.0分 |
| 108 | 北陆药业 | -13.32% | -1.61% | 5.2分 |
| 110 | 悦康药业 | -14.05% | 8.08% | 4.3分 |
| 112 | 拓新药业 | -14.24% | 4.77% | 4.3分 |
| 114 | 亨迪药业 | -14.59% | 5.63% | 4.9分 |
| 116 | - | -14.88% | 0.53% | 分 |
| 118 | 西点药业 | -15.04% | 2.75% | 5.1分 |
| 120 | 广济药业 | -15.25% | 1.98% | 5.2分 |
| 122 | 复旦张江 | -15.31% | 2.02% | 4.6分 |
| 124 | 亚虹医药 | -15.81% | 3.66% | 4.4分 |
| 126 | 前沿生物 | -16.21% | 4.40% | 4.4分 |
| 128 | 花园生物 | -16.72% | 3.21% | 4.6分 |
| 130 | 中关村 | -16.99% | 2.14% | 4.9分 |
| 132 | 新天地 | -17.29% | 0.56% | 4.8分 |
| 134 | 仟源医药 | -18.43% | 2.71% | 5.0分 |
| 136 | - | -18.54% | 0.84% | 分 |
| 138 | 誉衡药业 | -18.97% | 3.10% | 5.2分 |
| 140 | 赛托生物 | -19.60% | 1.82% | 4.4分 |
| 142 | *ST集友 | -19.65% | -2.39% | 3.9分 |
| 144 | 宏辉果蔬 | -20.00% | 2.98% | 4.6分 |
| 146 | 华北制药 | -20.73% | 5.05% | 4.9分 |
| 148 | 联环药业 | -21.01% | 3.13% | 5.2分 |
| 150 | 哈三联 | -22.15% | 2.13% | 5.3分 |
| 152 | 石药创新 | -23.68% | 7.11% | 5.1分 |
| 154 | 美诺华 | -23.90% | 3.59% | 5.3分 |
| 156 | 哈药股份 | -24.90% | 0.00% | 5.6分 |
| 158 | 神奇制药 | -26.61% | 1.75% | 4.9分 |
| 160 | 键凯科技 | -30.15% | -1.86% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 95/217 ， 115/217。
[{"date":"2026-09-30","value":"2.26","vol":"-3.64"},{"date":"2026-06-30","value":"2.00","vol":"-0.06"},{"date":"2026-03-31","value":"1.00","vol":"0.46"},{"date":"2025-12-31","value":"6.98","vol":"-1.74"},{"date":"2025-09-30","value":"5.97","vol":"1.57"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.26 | 2.00 | 1.00 | 6.98 | 5.97 |
| 行业(%) | -3.64 | -0.06 | 0.46 | -1.74 | 1.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"29.09","vol":"49.28"},{"date":"2026-06-30","value":"29.60","vol":"49.07"},{"date":"2026-03-31","value":"30.20","vol":"50.10"},{"date":"2025-12-31","value":"32.43","vol":"49.45"},{"date":"2025-09-30","value":"33.29","vol":"49.28"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
29.09 | 29.60 | 30.20 | 32.43 | 33.29 |
| 行业(%) | 49.28 | 49.07 | 50.10 | 49.45 | 49.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 135/217 ， 130/217。
[{"date":"2026-09-30","value":"-19.29","vol":"42.64"},{"date":"2026-06-30","value":"-19.22","vol":"19.66"},{"date":"2026-03-31","value":"-20.81","vol":"23.45"},{"date":"2025-12-31","value":"-14.39","vol":"37.42"},{"date":"2025-09-30","value":"-19.47","vol":"139.36"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-19.29 | -19.22 | -20.81 | -14.39 | -19.47 |
| 行业(%) | 42.64 | 19.66 | 23.45 | 37.42 | 139.36 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"-61.18","vol":"149.72"},{"date":"2026-06-30","value":"-58.99","vol":"353.66"},{"date":"2026-03-31","value":"-61.71","vol":"48.30"},{"date":"2025-12-31","value":"-13.11","vol":"-23.63"},{"date":"2025-09-30","value":"-16.07","vol":"3.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-61.18 | -58.99 | -61.71 | -13.11 | -16.07 |
| 行业(%) | 149.72 | 353.66 | 48.30 | -23.63 | 3.94 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 76/217 ， 47/217。
[{"date":"2026-09-30","value":"0.29","vol":"0.31"},{"date":"2026-06-30","value":"0.20","vol":"0.21"},{"date":"2026-03-31","value":"0.11","vol":"0.10"},{"date":"2025-12-31","value":"0.48","vol":"0.41"},{"date":"2025-09-30","value":"0.35","vol":"0.30"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.29 | 0.20 | 0.11 | 0.48 | 0.35 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.41 | 0.30 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"2.11","vol":"1.94"},{"date":"2026-06-30","value":"1.52","vol":"1.30"},{"date":"2026-03-31","value":"0.80","vol":"0.65"},{"date":"2025-12-31","value":"3.20","vol":"2.59"},{"date":"2025-09-30","value":"2.20","vol":"1.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.11 | 1.52 | 0.80 | 3.20 | 2.20 |
| 行业(次) | 1.94 | 1.30 | 0.65 | 2.59 | 1.94 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"1.15","vol":"-0.33"},{"date":"2026-06-30","value":"21.94","vol":"5.40"},{"date":"2026-03-31","value":"-17.60","vol":"-2.46"},{"date":"2025-12-31","value":"22.78","vol":"15.68"},{"date":"2025-09-30","value":"23.19","vol":"4.82"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 1.15 | 21.94 | -17.60 | 22.78 | 23.19 |
| 行业 | -0.33 | 5.40 | -2.46 | 15.68 | 4.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.30","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.36","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.30 | - | 0.36 | - |
| 行业 | 0.00 | 1.31 | 0.00 | 1.59 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 97/217 ， 81/217。
[{"date":"2026-09-30","value":"3.40","vol":"3.64"},{"date":"2026-06-30","value":"3.53","vol":"3.68"},{"date":"2026-03-31","value":"3.59","vol":"3.65"},{"date":"2025-12-31","value":"3.59","vol":"3.44"},{"date":"2025-09-30","value":"3.21","vol":"3.52"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.40 | 3.53 | 3.59 | 3.59 | 3.21 |
| 行业 | 3.64 | 3.68 | 3.65 | 3.44 | 3.52 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.79","vol":"2.95"},{"date":"2026-06-30","value":"1.63","vol":"2.98"},{"date":"2026-03-31","value":"1.76","vol":"3.01"},{"date":"2025-12-31","value":"1.68","vol":"2.82"},{"date":"2025-09-30","value":"1.71","vol":"2.78"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.79 | 1.63 | 1.76 | 1.68 | 1.71 |
| 行业 | 2.95 | 2.98 | 3.01 | 2.82 | 2.78 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 108/217 ， 103/217。
[{"date":"2026-09-30","value":"17.81","vol":"32.58"},{"date":"2026-06-30","value":"17.76","vol":"33.24"},{"date":"2026-03-31","value":"17.59","vol":"32.97"},{"date":"2025-12-31","value":"17.59","vol":"34.15"},{"date":"2025-09-30","value":"18.79","vol":"33.59"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.81 | 17.76 | 17.59 | 17.59 | 18.79 |
| 行业(%) | 32.58 | 33.24 | 32.97 | 34.15 | 33.59 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.25","vol":"0.66"},{"date":"2026-06-30","value":"0.25","vol":"0.70"},{"date":"2026-03-31","value":"0.25","vol":"9.64"},{"date":"2025-12-31","value":"0.25","vol":"1.73"},{"date":"2025-09-30","value":"0.27","vol":"1.17"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.25 | 0.25 | 0.25 | 0.25 | 0.27 |
| 行业(%) | 0.66 | 0.70 | 9.64 | 1.73 | 1.17 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"6.28","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.92","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"10.84","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.42","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]